Cyclo Therapeutics Stock (NASDAQ: CYTH) stock price, news, charts, stock research, profile.
You can purchase shares of Cyclo Therapeutics (NASDAQ:CYTH) through any online brokerage.
Other companies in Cyclo Therapeutics’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Curis (NASDAQ:CRIS), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP) and Nanoviricides (AMEX:NNVC).
Cyclo Therapeutics has a consensus price target of $0.95.
The stock price for Cyclo Therapeutics (NASDAQ: CYTH) is $0.8701 last updated February 21, 2025 at 7:55 PM EST.
There are no upcoming dividends for Cyclo Therapeutics.
Cyclo Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.
There is no upcoming split for Cyclo Therapeutics.
Cyclo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.